$-0.21 EPS Expected for Aemetis Inc (AMTX)

October 31, 2017 – By Marguerite Chambers

Wall Street await Aemetis Inc (NASDAQ:AMTX) to release earnings on November, 13. Analysts forecast earnings per share of $-0.21, exactly $0.00 or 0.00 % from 2014’s $-0.21 EPS. After posting $-0.30 EPS for the previous quarter, Aemetis Inc’s analysts now forecast -30.00 % EPS growth. The stock increased 11.00% or $0.077 on October 30, reaching $0.78. About 64,807 shares traded or 79.98% up from the average. Aemetis Inc (NASDAQ:AMTX) has declined 50.79% since October 31, 2016 and is downtrending. It has underperformed by 67.49% the S&P500.

Aemetis, Inc. is an international renewable fuels and biochemicals company. The company has market cap of $15.46 million. The Firm is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum products by conversion of first-generation ethanol and biodiesel plants into biorefineries. It currently has negative earnings. The Company’s divisions include North America and India.

Another recent and important Aemetis Inc (NASDAQ:AMTX) news was published by Seekingalpha.com which published an article titled: “Aemetis – Changes Bring More Potential Upside” on May 26, 2016.